Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

879
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
879
Epigenetic Regulation01:46

Epigenetic Regulation

33.8K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.8K
GTPases and their Regulation02:14

GTPases and their Regulation

9.9K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.9K
Regulated Protein Degradation02:58

Regulated Protein Degradation

8.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Master Transcription Regulators02:23

Master Transcription Regulators

7.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

38.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mid-Study Inclusion of Non-Incarcerated Participants Who Meet the Definition of a "Prisoner" Under 45 CFR 46 Subpart C.

The American journal of bioethics : AJOB·2026
Same author

Associations of Prenatal Cannabis Exposure and Neonatal Brain Development in the HBCD Cohort.

medRxiv : the preprint server for health sciences·2026
Same author

Retaining infants and young children who experience transitions in care in longitudinal studies of child health and development: Considerations from the HEALthy Brain and Child Development study.

Infant mental health journal·2025
Same author

Presence of Institutional Guidance on Research-Related Transportation Could Help Reduce Barriers to and Disparities in Research Engagement.

Journal of clinical and translational science·2025
Same author

Navigating ethical and legal challenges in the HEALthy Brain and Child Development Study: Lessons learned from the ethics, law, policy working group.

Developmental cognitive neuroscience·2024
Same author

LAP2α orchestrates alternative lengthening of telomeres suppression through telomeric heterochromatin regulation with HDAC1: unveiling a potential therapeutic target.

Cell death & disease·2024

Related Experiment Video

Updated: Feb 5, 2026

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.6K

Regulating stool for microbiota transplantation.

Pilar N Ossorio1,2, Yao Zhou2

  • 1a Ethics Program, Law School , University of Wisconsin-Madison , Madison , WI, USA.

Gut Microbes
|September 14, 2018
PubMed
Summary

The study argues that microbiota transplantation (MT), despite a proposed definition to differentiate it from biologic drugs, should face similar regulatory oversight due to potential patient risks. The authors suggest current definitions may be difficult for regulators to implement.

Keywords:
FDAFMTHCT/Pfecalmicrobiomemicrobiota transplantationminimal manipulationoversightregulationstool

More Related Videos

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.7K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K

Related Experiment Videos

Last Updated: Feb 5, 2026

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.6K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.7K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K

Area of Science:

  • Microbiology
  • Regulatory Science
  • Gastroenterology

Background:

  • A 2017 publication proposed a definition to distinguish microbiota transplantation (MT) from biologic drugs.
  • The authors suggested MT need not be regulated as a biologic drug, specifically a live biotherapeutic product.

Purpose of the Study:

  • To evaluate the proposed definition of microbiota transplantation (MT) for regulatory purposes.
  • To argue for commensurate regulatory oversight for MT products based on patient risk.
  • To assess the operational feasibility of the proposed MT definition for regulatory agencies.

Main Methods:

  • Critical analysis of a proposed definition for microbiota transplantation (MT).
  • Risk-benefit assessment comparing MT products with other microbial-derived products.
  • Evaluation of regulatory frameworks for medical products.

Main Results:

  • The proposed definition of MT may not adequately address the potential risks associated with products like stool transplants.
  • MT products, particularly those using less manipulated materials, pose significant risks comparable to or greater than regulated biologic drugs.
  • The proposed definition might be challenging for regulatory bodies to implement effectively.

Conclusions:

  • Microbiota transplantation (MT) should be subject to the same stringent regulatory oversight as other biologic products due to inherent patient risks.
  • Regulatory agencies must ensure oversight is proportionate to the risk profile of medical products, including MT.
  • The operationalization of the proposed MT definition requires further consideration to ensure effective regulation.